Take a deeper dive

Nuventra’s Webinar Library

Were you unable to attend our live webinars? Watch Nuventra’s past webinars and hear directly from some of our Senior Consultants who are experts on these Clinical Pharmacology topics.  Fill out the forms below for more details and to access our past webinars recordings.

Timing Considerations for Clinical Pharmacology Studies in Oncology Drug Development

Clinical pharmacology plans are not “one size fits all.” This is especially true for oncology, as the time from the first-in-human dose to approval is shorter for oncology relative to other indications and the medical need is substantial. Hear from Nuventra’s consultants, Gene Williams and Brian Furmanski as they present this webinar titled, “Timing Considerations for Clinical Pharmacology Studies in Oncology Drug Development.

Oncology Webinar

Designing Smarter Clinical Trials with Modeling & Simulation Approaches

With modeling and simulation, your existing data can be leveraged to provide important insights, design more efficient trials, and used to potentially avoid certain clinical studies, saving money and time. This webinar will cover modeling and simulation fundamentals, real-world examples, and best practices to implement in your development program. Hear from Mark Sale, M.D., and Lauren Lohmer, Ph.D. as they present the webinar titled, “Designing Smarter Clinical Trials with Modeling & Simulation Approaches.”

Modeling & Simulation Webinar

The Path to IND – Roadblocks, Milestones, and Regulatory Strategy

The Investigational New Drug (IND) application is the primary pathway through which new drugs and biologics are approved to be tested in humans. But, what exactly is an IND and does your program really need one? What are the requirements for a successful IND and what paths can you take to get there? Hear from Todd Shearer, Ph.D. and Brian Furmanski, Ph.D., as they present this webinar titled, “The Path to IND – Roadblocks, Milestones, and Regulatory Strategy.

The Path to IND Webinar

Addressing the Challenges of Drug Discovery and Delivery for Combination Peptide Therapeutics

There has been growing interest and activity in the use of peptide therapeutics to treat a variety of human diseases. This webinar will present approaches to discover, optimize, assess, and deliver combination peptide therapeutics for treatment of metabolic diseases. Hear from Nuventra’s Mark Bush PhD, and Intarcia Therapeutics’ Paul L. Feldman PhD, as they present this webinar titled, “Addressing the Challenges of Drug Discovery and Delivery for Combination Peptide Therapeutics.

Peptide Webinar

Explore Our Blog

Balance

What is a Human Mass Balance Study?

A human mass balance clinical study aims to understand how drugs are absorbed, metabolized, and excreted after dosing. This information…

Read More

Pharmacokinetics in Patients with Hepatic Impairment

The liver is responsible for the metabolism and clearance of many different drugs and their metabolites. Because of the liver’s…

Read More

Surrogate Endpoints – Neither the End nor the Point

In an article published in June 2018 in JAMA Oncology, the FDA reviewed their accelerated approvals for malignant hematology and…

Read More